Pulse Biosciences, Inc.
PLSE
$16.49
-$0.56-3.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.54% | -41.59% | -26.95% | -16.87% | 6.24% |
| Total Depreciation and Amortization | -5.25% | -3.49% | -2.40% | -3.55% | -6.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.33% | 117.38% | 88.94% | 72.74% | -26.34% |
| Change in Net Operating Assets | 209.62% | 150.00% | 221.88% | 143.27% | -82.25% |
| Cash from Operations | -25.54% | -10.57% | -9.99% | 0.71% | -3.13% |
| Capital Expenditure | -139.00% | -89.66% | -3.31% | 3.36% | 36.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -159.00% | -89.66% | -3.31% | 3.36% | 36.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 8,080.16% | 670.47% | 573.55% | 303.88% | -89.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.92% | -4,583.33% | -4,583.33% | -3,600.00% | -5,480.00% |
| Cash from Financing | 4,073.34% | 627.84% | 572.08% | 303.05% | -96.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 346.24% | 539.25% | 539.21% | 252.57% | -174.07% |